药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Lumiracoxib
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Vemurafenib.
Lumiracoxib
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Vemurafenib.
Lumiracoxib
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Vemurafenib.
Lumiracoxib
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Vemurafenib.
Lumiracoxib
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Vemurafenib.
Lumiracoxib
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Vemurafenib.
Lumiracoxib
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vemurafenib.
Lumiracoxib
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Vemurafenib.
Lumiracoxib
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vemurafenib.
Lumiracoxib
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Vemurafenib.
Lumiracoxib
Cycloguanil
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cycloguanil.
Lumiracoxib
Tetrandrine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Tetrandrine.
Lumiracoxib
Piperaquine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Piperaquine.
Lumiracoxib
Artemotil
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artemotil.
Lumiracoxib
Artemisinin
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artemisinin.
Lumiracoxib
Pyronaridine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pyronaridine.
Lumiracoxib
Mizoribine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Mizoribine.
Lumiracoxib
Chlorproguanil
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Chlorproguanil.
Lumiracoxib
Artefenomel
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artefenomel.
Lumiracoxib
Artenimol
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artenimol.